| Line item | 2025-09-28 FY | 2024-09-29 FY | 2023-10-01 FY | 2022-10-02 FY | 2021-10-03 FY |
|---|---|---|---|---|---|
| Revenue | $37.18B | $36.18B | $35.98B | $32.25B | $29.06B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $2.62B | $2.52B | $2.44B | $2.03B | $1.93B |
| Operating Income | $2.94B | $5.41B | $5.87B | $4.62B | $4.87B |
| Interest Expense | $542.60M | $562.00M | $550.10M | $482.90M | $469.80M |
| Tax Expense | $650.60M | $1.21B | $1.28B | $948.50M | $1.16B |
| Net Income | $1.86B | $3.76B | $4.12B | $3.28B | $4.20B |
| EPS (basic) | 1.6300 | 3.3200 | 3.6000 | 2.8500 | 3.5700 |
| EPS (diluted) | 1.6300 | 3.3100 | 3.5800 | 2.8300 | 3.5400 |
| Shares (diluted) | $1.14B | $1.14B | $1.15B | $1.16B | $1.19B |